Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.1 USD | +0.55% | -8.12% | -12.01% |
02:00pm | Goldman Sachs Cuts Bristol-Myers Squibb's Price Target to $56 From $60 | MT |
12:54pm | Deutsche Bank Adjusts Price Target on Bristol-Myers Squibb to $53 From $55, Keeps Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.01% | 90.92B | |
+26.82% | 661B | |
+27.40% | 566B | |
-6.37% | 352B | |
+20.39% | 332B | |
+2.92% | 283B | |
+13.96% | 231B | |
+5.17% | 200B | |
-9.08% | 195B | |
-5.00% | 145B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- UBS Cuts Bristol-Myers Squibb Price Target to $52 From $57, Maintains Neutral Rating